TH-17 cells in the circle of immunity and autoimmunity

Nature Immunology

Volumn 8, Issue 4, 2007, Pages 345-350

  Bettelli, Estelle ^a   Oukka, Mohamed ^b   Kuchroo, Vijay K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CELL NUCLEUS RECEPTOR; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 27; INTERLEUKIN 6; NUCLEAR RECEPTOR ROR GAMMA T; PROTEIN P19; STAT1 PROTEIN; STAT4 PROTEIN; STAT6 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELL MATURATION; CELL SURVIVAL; CELLULAR IMMUNITY; HELPER CELL; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATORY CELL; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN STRUCTURE; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; TH 17 CELL; TH1 CELL; TH2 CELL;

ANIMALS; AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; HUMANS; INTERLEUKIN-17; RECEPTORS, INTERLEUKIN-17; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 34248572345     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni0407-345     Document Type: Article

References (73)

1. H2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145-173 (1989).
2. Abbas, A.K., Murphy, K.M. & Sher, A. Functional diversity of helper T lymphocytes. Nature 383, 787-793 (1996).
3. Shevach, E.M. From vanilla to 28 flavors: Multiple varieties of T regulatory cells. Immunity 25, 195-201 (2006).
4. Sakaguchi, S. Regulatory T cells: Key controllers of immunologic self-tolerance. Cell 101, 455-458 (2000).
5. Faria, A.M. & Weiner, H.L. Oral tolerance and TGF-beta-producing cells. Inflamm. Allergy Drug Targets 5, 179-190 (2006).
6. Wan, Y.Y. & Flavell, R.A. The roles for cytokines in the generation and maintenance of regulatory T cells. Immunol. Rev. 212, 114-130 (2006).
7. Willenborg, D.O., Fordham, S., Bernard, C.C., Cowden, W.B. & Ramshaw, I.A. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157, 3223-3227 (1996).
8. Krakowski, M. & Owens, T, Interferon-γ confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 26 1641-1646 (1996).
9. Willenborg, D.O., Fordham, S.A., Staykova, M.A., Ramshaw, I.A. & Cowden, W.B. IFN-γ is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: A possible role for nitric oxide. J. Immunol. 163, 5278-5286 (1999).
10. Tran, E.H., Prince, E.N. & Owens, T. IFN-γ shapes immune invasion of the central nervous system via regulation of chemokines. J. Immunol. 164, 2759-2768 (2000).
11. Cua, D.J. et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744-748 (2003).
12. Langrish, C.L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233-240 (2005).
13. Bettelli, E. & Kuchroo, V.K. IL-12- and IL-23-incluced T helper cell subsets: Birds of the same feather flock together. J. Exp. Med. 201, 169-171 (2005).
14. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123-1132 (2005).
15. Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133-1141 (2005).
16. Veldhoen, M., Hocking, R.J., Atkins, C.J., Locksley, R.M. & Stockinger, B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179-189 (2006).
17. H17 and regulatory T cells. Nature 441, 235-238 (2006).
18. H17 lineage. Nature 441, 231-234 (2006).
19. Aggarwal, S. & Gurney, A.L. IL-17: Prototype member of an emerging cytokine family. J. Leukoc. Biol. 71, 1-8 (2002).
20. Moseley, T.A., Haudenschild, D.R., Rose, L. & Reddi, A.H. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 14, 155-174 (2003).
21. Kolls, J.K. & Linden, A. Interleukin-17 family members and inflammation. Immunity 21, 467-476 (2004).
22. Fossiez, F. et al. Tcell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183, 2593-2603 (1996).
23. Ye, P. et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194, 519-527 (2001).
24. Matusevicius, D. et al. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult. Scler. 5, 101-104 (1999).
25. Wong, C.K., Ho, C.Y., Li, E.K. & Lam, C.W. Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythernatosus. Lupus 9, 589-593 (2000).
26. Hashimoto, T., Akiyama, K., Kobayashi, N. & Mori, A. Comparison of IL-17 production by helper T cells among atopic and nonatopic asthmatics and control subjects. Int. Arch. Allergy Immunol. 137, 51-54 (2005).
27. Linden, A., Hoshino, H. & Laan, M. Airway neutrophils and interleukin-17. Eur. Respir. J. 15, 973-977 (2000).
28. Nakae, S., Nambu, A., Sudo, K. & Iwakura, Y. Suppression of immune induction of collagen-incluced arthritis in IL-17-deficient mice. J. Immunol. 171, 6173-6177 (2003).
29. Bush, K.A., Farmer, K.M., Walker, J.S. & Kirkham, B.W. Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein. Arthritis Rheum. 46, 802-805 (2002).
30. Komiyama, Y. et al. IL-I 7 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177, 566-573 (2006).
31. Hofstetter, H.H. et al. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell. Immunol. 237, 123-130 (2005).
32. Liang, S.C. et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203, 2271-2279 (2006).
33. Wolk, K. & Sabat, R. Interleukin-22: A novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev. 17, 367-380 (2006).
34. + T lymphocytes. Cell Res. 16, 902-907 (2006).
35. Zheng, Y. et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445 648-651 (2007).
36. Aggarwal, S., Ghilardi, N., Xie, M.H., de Sauvage, F.J. & Gurney, A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278, 1910-1914 (2003).
37. Langrish, C.L. et al. IL-12 and IL-23: Master regulators of innate and adaptive immunity. Immunol. Rev. 202, 96-105 (2004).
38. Parham, C. et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168, 5699-5708 (2002).
39. H1 cells before IL-12-dependent selection. Science 292, 1907-1910 (2001).
40. Sutton, C., Brereton, C., Keogh, B., Mills, K.H. & Lavelle, E.C. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203, 1685-1691 (2006).
41. Liu, X.K., Clements, J.L. & Gaffen, S.L. Signaling through the murine T cell receptor induces IL-17 production in the absence of costimulation, IL-23 or dendritic cells. Mol. Cells 20, 339-347 (2005).
42. Nakae, S. et al. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc. Natl. Acad. Sci. USA 100, 5986-5990 (2003).
43. + T cells. Immunity 16, 779-790 (2002).
44. Hunter, C.A. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5, 521-531 (2005).
45. Batten, M. et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7, 929-936 (2006).
46. Stumhofer, J.S. et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7, 937-945 (2006).
47. Chen, Y. et al. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J. Clin. Invest. 116, 1317-1326 (2006).
48. Rangachari, M. et al. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J. Exp. Med. 203, 2009-2019 (2006).
49. Mathur, A.N. et al. T-bet is a critical determinant in the instability of the IL-17-secreting T-helper phenotype. Blood 108, 1595-1601 (2006).
50. + T helper cells. Cell 126, 1121-1133 (2006).
51. Dzhagalov, I., Zhang, N. & He, Y.W. The roles of orphan nuclear receptors in the development and function of the immune system. Cell. Mol. Immunol. 1, 401-407 (2004).
52. + cells. Science 305, 248-251 (2004).
53. Akimzhanov, A.M., Yang, X.O. & Dong, C. Chromatin remodeling at IL17-IL-17F cytokine gene focus during inflammatory helper T cell differentiation. J. Biol. Chem. published online ahead of print 11 January 2007 (doi:10.1074/jbc.C600322200).
54. Powrie, F. & Coffman, R.L. Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol. Today 14, 270-274 (1993).
55. Khoury, S.J., Hancock, W.W. & Weiner, H.L. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 176, 1355-1364 (1992).
56. Merrill, J.E. et al. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc. Natl. Acad. Sci. USA 89, 574-578 (1992).
57. Chitnis, T. et al. Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis. J. Clin. Invest 108, 739-747 (2001).
58. Bettelli, E. et al. Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. J. Exp. Med. 200, 79-87 (2004).
59. Lovett-Racke, A.E. et al. Silencing T-bet defines a critical role in the differentiation of autoreactive T lymphocytes. Immunity 21, 719-731 (2004).
60. Panitch, H.S. Interferons in multiple sclerosis. A review of the evidence. Drugs 44, 946-962 (1992).
61. Jones, L.S. et al. IFN-γ-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. J. Immunol. 158, 5997-6005 (1997).
62. Murphy, C.A. et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198, 1951-1957 (2003).
63. Segal, B.M., Dwyer, B.K. & Shevach, E.M. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 187, 537-546 (1998).
64. H2 cells in Stat4-deficient mice. Nature 382, 174-177 (1996).
65. Szabo, S.J. et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100, 655-669 (2000).
66. Korn, T. et al. Myelin-specific regulatory T-cells accumulate in the central nervous system, but fail to suppress pathogenic effector T-cells at the peak of autoimmune inflammation. Nat. Med. (in the press).
67. Kim, J.M., Rasmussen, J.P. & Rudensky, A.Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8, 191-197 (2007).
68. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886 (2003).
69. + regulatory T cells responsible for protection against diabetes. Proc. Natl. Acad. Sci. USA 101, 4572-4577 (2004).
70. Kretschmer, K. et al. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol. 6, 1219-1227 (2005).
71. Lohr, J., Knoechel, B., Wang, J.J., Villarino, A.V. & Abbas, A.K. Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J. Exp. Med. 203, 2785-2791 (2006).
72. Woo, P. et al. Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: Proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement. Arthritis Res. Ther. 7, R1281-R1288 (2005).
73. Maini, R.N. et al. Double-blind randomized controlled clinical trial ofthe interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate. Arthritis Rheum. 54, 2817-2829 (2006).